CH
Cochlear Limited
CHEOF · OTC
$96.71 +0.00% (+$0.00)
1M +0.74%
Market Cap $8.92B
P/E Ratio 60.64x
Div. Yield 3.03%
ROE 7.85%
Bulios Fair Price
$49.18
49.1% downside
Current Price
$96.71
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHEOF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
26 /100
Expensive EV/EBITDA 22.01x
P/S 3.83x
P/B 5.13x
Growth
32 /100
Declining Rev. growth 6.39%
FCF growth 4.77%
Book val. growth 0.21%
Profitability
69 /100
Strong Net margin 6.31%
Op. margin 12.89%
FCF margin 13.15%
Quality
53 /100
Average ROE 7.85%
ROA 5.66%
Asset turnover 0.90x
Debt
100 /100
Low Current ratio 2.15x
Int. coverage 22.80x
Net debt/EBITDA 0.06x
Stability
62 /100
Moderate Rev. volatility 8.13%
EPS volatility 44.37%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHEOF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Diggory William Howitt
Employees
5,400
Headquarters
Sydney
Upcoming events
21 SEP
Ex-Dividend
Ex-dividend date
14 OCT
Dividend Payment
Payment date
16 FEB
Earnings
Upcoming earnings report